BAL PHARMA
Back to Cashflow Statement
|
BAL PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹31 Cr | ₹20 Cr | ₹23 Cr | ₹-1.54 Cr | ₹27 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAL PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹31 Cr |
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹-1.54 Cr |
| Mar2022 | ₹27 Cr |
How is Cash Flow from Operating Activities of BAL PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹31 Cr | 51.78 | |
| Mar2025 | ₹20 Cr | -10.92 | |
| Mar2024 | ₹23 Cr | Positive | |
| Mar2023 | ₹-1.54 Cr | Negative | |
| Mar2022 | ₹27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹132.8 Cr | -2.5% | -1.1% | 6.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -2.5% |
-1.1% |
6.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses